People with type 2 diabetes who are already showing signs of some kidney damage may be able to significantly lower their risk of death by treating multiple risk factors at once.

According to a new trial, just 15 minutes of Individualized, physician-directed lifestyle counseling appears to help diabetic patients increase physical activity and lose weight.

On January 18, the FDA approved a new indication for colesevelam HCl 625-mg tablets as adjunctive therapy to improve glycemic control in adults with type 2 diabetes. Colesevelam can be added to metformin, sulfonylureas, or insulin, either alone or in combination with other antidiabetic agents.

The results of the study over three years confirms that optimal diabetes care requires a team effort.

New research suggests that individuals with a high body mass index (BMI) and high systolic blood pressure are at an increased risk for stroke mortality.

Researchers have discovered new cellular mechanisms that lead to in insulin resistance in people with diabetes.

For critically ill patients, intensive insulin therapy (IIT) to keep blood sugar (glucose) at normal levels reduces the risk of acute kidney injury, reports a new study.

Neurological evaluation of diabetics indicates that there is relationship between diminished vascular endothelial growth factor (VEGF) expression and neuropathy.

Diagnosing diabetes and prediabetes with just a fasting blood sugar can sometimes fail us. We know that a person can have a normal fasting blood sugar, yet can have an elevated postprandial blood sugar on any given day. For the first time, we now have a new product, Diabetes Risk …

Medtronic Inc said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder. The U.S. medical device maker said patients wear the device for three days, after which physicians can review the data and use the results to uncover glucose patterns.